Company Performance - Kinsale Capital Group, Inc. (KNSL) closed at $391.12, reflecting a -1.14% change from the previous day, underperforming the S&P 500's daily loss of 0.74% [1] - Over the past month, KNSL shares have increased by 5.28%, while the Finance sector gained 2.1% and the S&P 500 rose by 0.79% [1] Upcoming Earnings - Analysts expect Kinsale Capital Group, Inc. to report earnings of $5.24 per share, indicating a year-over-year growth of 13.42% [2] - The consensus estimate for revenue is $471.37 million, which represents a 14.38% increase from the prior-year quarter [2] Full Year Projections - For the full year, Zacks Consensus Estimates project earnings of $18.9 per share and revenue of $1.86 billion, reflecting changes of +17.68% and +17.25% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Kinsale Capital Group, Inc. are important as they often reflect shifting business dynamics, with positive revisions indicating analyst optimism [4] Zacks Rank and Valuation - Kinsale Capital Group, Inc. currently holds a Zacks Rank of 3 (Hold), with the consensus EPS projection having moved 0.09% higher in the past 30 days [6] - The company is trading at a Forward P/E ratio of 20.93, which is a premium compared to the industry average Forward P/E of 11.51 [7] PEG Ratio - KNSL has a PEG ratio of 1.42, which is lower than the average PEG ratio of 1.67 for the Insurance - Property and Casualty industry [8] Industry Overview - The Insurance - Property and Casualty industry is part of the Finance sector and currently holds a Zacks Industry Rank of 45, placing it in the top 19% of over 250 industries [9]

Company Performance - Dynatrace (DT) closed at $43.34, down 1.72% from the previous trading session, underperforming the S&P 500, which fell by 0.74% [1] - The stock has decreased by 1.78% over the past month, while the Computer and Technology sector gained 0.14% and the S&P 500 increased by 0.79% [1] Earnings Projections - The upcoming EPS for Dynatrace is projected at $0.41, indicating a 10.81% increase year-over-year [2] - Quarterly revenue is estimated to be $505.77 million, reflecting a 15.96% increase from the same period last year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at $1.63 per share and revenue at $1.99 billion, representing increases of 17.27% and 17.21% respectively from the prior year [3] Analyst Estimates - Changes in analyst estimates for Dynatrace are crucial as they reflect short-term business trends and can influence stock performance [4] - Positive revisions in estimates indicate analysts' confidence in the company's performance and profit potential [4] Zacks Rank and Valuation - Dynatrace currently holds a Zacks Rank of 3 (Hold), with no changes in the consensus EPS estimate over the past month [6] - The company has a Forward P/E ratio of 27.02, which is higher than the industry average of 17.48 [7] - The PEG ratio for Dynatrace is 1.9, compared to the industry average PEG ratio of 1.82 [7] Industry Context - The Computers - IT Services industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 78, placing it in the top 32% of over 250 industries [8] - Strong industry rankings correlate with stock performance, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [8]

Core Viewpoint - Rithm (RITM) is experiencing a decline in stock price and is expected to report lower earnings and revenue in the upcoming earnings release [1][2]. Group 1: Stock Performance - Rithm's stock closed at $10.90, reflecting a -1.54% change from the previous day's closing price, which is worse than the S&P 500's daily loss of 0.74% [1]. - Prior to the recent trading session, Rithm's shares had decreased by 2.29%, underperforming compared to the Finance sector's gain of 2.1% and the S&P 500's gain of 0.79% [1]. Group 2: Earnings Expectations - Rithm is anticipated to report an EPS of $0.54, which represents a 10% decrease from the same quarter last year [2]. - The consensus estimate for Rithm's revenue is $1.37 billion, indicating a significant decline of 34.89% from the prior-year quarter [2]. - For the full year, analysts expect earnings of $2.14 per share and revenue of $4.46 billion, reflecting changes of +1.9% and -14.84%, respectively, from the previous year [3]. Group 3: Analyst Forecasts and Valuation - Recent revisions to analyst forecasts for Rithm are important as they may indicate changes in near-term business trends, with positive revisions suggesting optimism about the business outlook [4]. - The Zacks Rank system, which evaluates estimate changes, currently ranks Rithm at 3 (Hold), with a consensus EPS projection that has decreased by 1.61% in the past 30 days [6]. - Rithm has a Forward P/E ratio of 5.18, which is a discount compared to the industry average Forward P/E of 12.09 [6]. Group 4: Industry Context - Rithm operates within the Financial - Miscellaneous Services industry, which is part of the Finance sector and currently holds a Zacks Industry Rank of 96, placing it in the top 39% of over 250 industries [7].

Company Performance - Medpace (MEDP) closed at $561.65, reflecting a -1.27% change from the previous day, underperforming the S&P 500's loss of 0.74% [1] - Prior to the latest trading session, Medpace shares had declined by 2.54%, contrasting with the Medical sector's loss of 0.8% and the S&P 500's gain of 0.79% [1] Earnings Forecast - Medpace is expected to report an EPS of $4.18, representing a 13.9% increase from the same quarter last year [2] - Revenue is forecasted to be $681.17 million, indicating a growth of 26.94% compared to the corresponding quarter of the prior year [2] Full Year Estimates - For the full year, analysts project earnings of $14.8 per share and revenue of $2.5 billion, reflecting increases of +17.18% and +18.68% respectively from the previous year [3] Analyst Estimates - Recent changes to analyst estimates for Medpace are important as they indicate shifts in near-term business trends, with positive revisions suggesting optimism about the business outlook [4] - The Zacks Rank system, which incorporates these estimate changes, currently assigns Medpace a rank of 2 (Buy) [6] Valuation Metrics - Medpace has a Forward P/E ratio of 38.45, which is a premium compared to the industry average Forward P/E of 15.5 [7] - The company also has a PEG ratio of 2.15, compared to the Medical Services industry's average PEG ratio of 1.72 [7] Industry Context - The Medical Services industry, which includes Medpace, has a Zacks Industry Rank of 165, placing it in the bottom 34% of over 250 industries [8] - Historically, the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Ginkgo Bioworks Holdings, Inc. (DNA) experienced a stock increase of +1.96% to $8.31, outperforming the S&P 500's daily loss of 0.74% [1] - Over the past month, the company's shares have declined by 5.12%, which is worse than the Medical sector's loss of 0.8% and the S&P 500's gain of 0.79% [1] Upcoming Earnings - The upcoming earnings release is anticipated to show an EPS of -$1.8, reflecting a 1.1% increase from the same quarter last year [2] - Revenue is forecasted at $37 million, indicating a 15.62% decrease compared to the same quarter last year [2] Fiscal Year Estimates - For the entire fiscal year, earnings are projected at -$5.94 per share, representing a 42.66% increase from the previous year [3] - Revenue for the fiscal year is estimated at $173 million, showing a 23.8% decline from the prior year [3] Analyst Estimates - Recent changes in analyst estimates for Ginkgo Bioworks are crucial as they reflect the evolving business trends [4] - Positive revisions in estimates are seen as indicators of analysts' confidence in the company's performance and profit potential [4] Zacks Rank and Industry Performance - The Zacks Rank system, which ranges from 1 (Strong Buy) to 5 (Strong Sell), currently places Ginkgo Bioworks at 3 (Hold) [6] - The Medical - Biomedical and Genetics industry, which includes Ginkgo Bioworks, holds a Zacks Industry Rank of 92, placing it in the top 38% of over 250 industries [7]

Quanta Services (PWR) closed the most recent trading day at $422.06, moving -1.57% from the previous trading session. The stock's change was less than the S&P 500's daily loss of 0.74%. At the same time, the Dow lost 0.63%, and the tech-heavy Nasdaq lost 0.76%. The stock of specialty contractor for utility and energy companies has fallen by 5.7% in the past month, lagging the Construction sector's loss of 2.42% and the S&P 500's gain of 0.79%.Investors will be eagerly watching for the performance of Quanta ...

Waste Management (WM) ended the recent trading session at $219.71, demonstrating a -1.08% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.74%. Meanwhile, the Dow experienced a drop of 0.63%, and the technology-dominated Nasdaq saw a decrease of 0.76%. Heading into today, shares of the garbage and recycling hauler had gained 3.53% over the past month, outpacing the Business Services sector's gain of 2.83% and the S&P 500's gain of 0.79%.The investment community w ...

Company Performance - Pilgrim's Pride (PPC) closed at $38.99, reflecting a -1.69% change from the previous day, underperforming the S&P 500's daily loss of 0.74% [1] - Over the last month, Pilgrim's Pride shares increased by 1.95%, outperforming the Consumer Staples sector's loss of 1% and the S&P 500's gain of 0.79% [1] Financial Projections - Pilgrim's Pride is projected to report earnings of $0.91 per share, indicating a year-over-year decline of 32.59% [2] - For the full year, Zacks Consensus Estimates forecast earnings of $5.45 per share and revenue of $0 million, showing changes of +0.55% and 0% respectively from the previous year [2] Analyst Estimates - Recent changes to analyst estimates for Pilgrim's Pride reflect short-term business trends, with positive revisions indicating a favorable outlook on business health and profitability [3] - The Zacks Rank system, which incorporates these estimate changes, provides actionable ratings for investors [4] Zacks Rank and Valuation - Pilgrim's Pride currently holds a Zacks Rank of 3 (Hold), with the Zacks Consensus EPS estimate remaining unchanged over the last 30 days [5] - The company has a Forward P/E ratio of 7.28, which is a discount compared to the industry average Forward P/E of 12.34 [6] Industry Context - The Food - Meat Products industry, part of the Consumer Staples sector, has a Zacks Industry Rank of 55, placing it in the top 23% of over 250 industries [6] - The strength of individual industry groups is measured by the Zacks Industry Rank, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [7]

Company Performance - Camtek (CAMT) closed at $106.35, reflecting a -2.08% change from the previous day, underperforming the S&P 500, which fell by 0.74% [1] - Over the past month, Camtek's shares have decreased by 2.07%, while the Computer and Technology sector gained 0.14% and the S&P 500 increased by 0.79% [2] Earnings Expectations - Analysts anticipate Camtek will report earnings of $0.83 per share, indicating a year-over-year growth of 7.79%. Revenue is expected to reach $127.21 million, up 8.46% from the same quarter last year [3] - For the full year, earnings are projected at $3.21 per share and revenue at $495.14 million, reflecting increases of +13.43% and +15.36% respectively from the previous year [4] Analyst Sentiment - Recent revisions to analyst estimates for Camtek suggest positive sentiment regarding the company's business and profitability, as these revisions are correlated with near-term share price momentum [5][4] - Camtek currently holds a Zacks Rank of 3 (Hold), with a recent 0.14% rise in the Zacks Consensus EPS estimate [6] Valuation Metrics - Camtek's Forward P/E ratio stands at 33.86, which is lower than the industry average of 44.66 [6] - The company has a PEG ratio of 2.17, compared to the industry average PEG ratio of 2.06 [7] Industry Context - The Electronics - Measuring Instruments industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 108, placing it in the top 44% of over 250 industries [8]

Core Viewpoint - Diebold Nixdorf, Incorporated is expected to show significant growth in its upcoming earnings report, with a notable increase in both EPS and revenue compared to the previous year [2][3]. Group 1: Stock Performance - The company's stock closed at $67.89, reflecting a decrease of 1.08% from the previous trading session, which is lower than the S&P 500's loss of 0.74% [1] - Over the past month, Diebold Nixdorf's shares have increased by 4.59%, outperforming the Computer and Technology sector's gain of 0.14% and the S&P 500's gain of 0.79% [1]. Group 2: Earnings Estimates - The upcoming earnings disclosure is anticipated to report an EPS of $1.73, representing a 78.35% increase from the same quarter last year [2]. - The consensus estimate for revenue is projected at $1.1 billion, indicating an 11.12% rise from the equivalent quarter last year [2]. - For the entire fiscal year, earnings are projected at $3.51 per share and revenue at $3.8 billion, reflecting increases of 54.63% and 1.31% respectively from the prior year [3]. Group 3: Analyst Forecasts - Recent revisions to analyst forecasts for Diebold Nixdorf are important as they reflect short-term business trends, with positive changes indicating a favorable outlook on business health and profitability [4]. - The Zacks Rank system, which assesses these estimate changes, currently ranks Diebold Nixdorf at 3 (Hold) [6]. Group 4: Valuation Metrics - Diebold Nixdorf is currently trading at a Forward P/E ratio of 19.55, which is a discount compared to the industry average Forward P/E of 28.86 [7]. - The Internet - Software industry, part of the Computer and Technology sector, has a Zacks Industry Rank of 51, placing it in the top 21% of over 250 industries [7].